| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/29/2003 | US6555667 Hypoxia-regulated genes |
| 04/29/2003 | US6555652 Tumor antigen peptide derivatives |
| 04/29/2003 | US6555520 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and immunologicval disorders |
| 04/29/2003 | US6555377 Process for production of mammalian cell lines |
| 04/29/2003 | US6555375 Methods for somatic embryo formation and plant regeneration of Beta vulgaris |
| 04/29/2003 | US6555374 Mixture of isolated extramedullary adipose tissue-derived stromal cell and a non-adipose derived cell capable of forming a blood cell |
| 04/29/2003 | US6555373 Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof |
| 04/29/2003 | US6555352 Peptide for use in human therapeutics and diagnostic compositions |
| 04/29/2003 | US6555345 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/29/2003 | US6555342 Fusion protein delivery system and uses thereof |
| 04/29/2003 | US6555341 Gamma-aminobutyric acid (GABA); stably co-transfected eukaryotic cell line capable of expressing a human GABAa receptor which comprises a theta receptor subunit and at least one receptor subunit; drug screening |
| 04/29/2003 | US6555340 Receptor for advanced glycation endproduct (RAGE); nucleic acid, vector and host cell; use in field of drug screening |
| 04/29/2003 | US6555339 Altering human G protein-coupled receptors (GPCRs) by point mutation; use in drug screening |
| 04/29/2003 | US6555338 Given nucleotide sequence; use of polynucleotides and polypeptides in diagnostic assays, and possibly functional genomics |
| 04/29/2003 | US6555337 Protein/transcription factor in basic-helix-loop-helix (bHLH) gene family which plays role in cell determination; genetic engineering |
| 04/29/2003 | US6555335 Xylanase from Trichoderma reesei , method for production thereof, and methods employing this enzyme |
| 04/29/2003 | US6555327 Monoclonal antibodies against S100 |
| 04/29/2003 | US6555325 Kit for screening of test compounds that modulate a heterologous G protein-coupled receptor in a yeast cell uses a mixture of yeast cells; modulators of heterologous receptors coupled to the pheromone response pathway in yeast |
| 04/29/2003 | US6555324 By means of flow cytometry, wherein said cells are labelled with fluorescently labelled monoclonal antibodies |
| 04/29/2003 | US6555321 Methods for determining cell responses through EphB receptors |
| 04/29/2003 | US6555319 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 04/29/2003 | US6555318 Method for identification of cell growth or differentiation factors |
| 04/29/2003 | US6555315 Capturing genes potentially encoding novel biochemical pathways of interest in prokaryotic systems, and screening for these pathways using high throughput screening assays |
| 04/29/2003 | US6555113 Elevating the ratio of circulating HDL to circulating LDL by administering a peptide conjugate of a helper T cell epitope portion linked to a B cell epitope portion; decrease in development of atherosclerotic lesions |
| 04/29/2003 | US6555107 Packaging cell |
| 04/29/2003 | US6555105 Method of treatment with a RANTES antagonist polypeptide |
| 04/29/2003 | CA2281206C Geranyl diphosphate synthase genes |
| 04/29/2003 | CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 04/29/2003 | CA2105804C Kainate-binding, human cns receptors of the eaa5 family |
| 04/29/2003 | CA2102208C Binding domains in notch and delta proteins |
| 04/29/2003 | CA1341428C Synthetic insecticidal crystal protein gene |
| 04/24/2003 | WO2003034076A1 Article handling system and method |
| 04/24/2003 | WO2003034075A1 Universal microscope slide cassette |
| 04/24/2003 | WO2003034074A1 Sensitivity controls for blood serology prepared from modified cells |
| 04/24/2003 | WO2003034038A2 Flow control metering system and method for controlling filtration of liquid-based specimens |
| 04/24/2003 | WO2003034037A2 Apparatus and method for destacking articles |
| 04/24/2003 | WO2003034036A1 Apparatus and method for mixing specimens in vials |
| 04/24/2003 | WO2003034034A2 Automated system and method for processing multiple liquid-based specimens |
| 04/24/2003 | WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | WO2003033705A1 Transgenic organism expressing fungal mrp-like abc transporters |
| 04/24/2003 | WO2003033704A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/24/2003 | WO2003033697A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 04/24/2003 | WO2003033687A2 Lift-off process for a hard etch mask for magnetic memory cells in mram devices |
| 04/24/2003 | WO2003033686A2 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 04/24/2003 | WO2003033685A2 Method of producing human beta cell lines |
| 04/24/2003 | WO2003033683A1 Microorganism and production of carotinoid compounds thereby |
| 04/24/2003 | WO2003033680A2 Kinases and phosphatases |
| 04/24/2003 | WO2003033678A2 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration |
| 04/24/2003 | WO2003033677A2 Dimerized growth factor and materials and methods for producing it |
| 04/24/2003 | WO2003033674A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/24/2003 | WO2003033664A2 Bone anti-resorptive compounds |
| 04/24/2003 | WO2003033659A2 Antisense modulation of matrix metalloproteinase 1 expression |
| 04/24/2003 | WO2003033654A2 Direct targeting binding proteins |
| 04/24/2003 | WO2003033653A2 Affinity enhancement agents |
| 04/24/2003 | WO2003033534A2 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 04/24/2003 | WO2003033519A2 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 04/24/2003 | WO2003033514A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/24/2003 | WO2003033463A2 Multimerized enhancer domains for cell-specific expression |
| 04/24/2003 | WO2003033394A1 Container uncapping apparatus and method |
| 04/24/2003 | WO2003032923A2 Induction of beta cell differentiation in human cells |
| 04/24/2003 | WO2003032920A2 Oligonucleotide modulation of cell adhesion |
| 04/24/2003 | WO2003032913A2 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/24/2003 | WO2003032898A2 Modified human thymic stromal lymphopoietin |
| 04/24/2003 | WO2003032814A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | WO2003032813A2 Methods for the treatment of carcinoma |
| 04/24/2003 | WO2003032810A2 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | WO2003032727A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 04/24/2003 | WO2003032713A2 COFFEE PLANT WITH REDUCED α-D-GALACTOSIDASE ACTIVITY |
| 04/24/2003 | WO2003014313A3 Alternative compositions and methods for the culture of stem cells |
| 04/24/2003 | WO2003007795A3 Tissue engineered heart valve |
| 04/24/2003 | WO2003007787A3 Cartilage repair and regeneration device and method |
| 04/24/2003 | WO2003005964A3 Recombinant vsv for the treatment of tumor cells |
| 04/24/2003 | WO2002098907A3 Cation conducting gabaa receptors and their use |
| 04/24/2003 | WO2002088706A3 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 04/24/2003 | WO2002077204A3 Stem cell differentiation |
| 04/24/2003 | WO2002074959A3 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
| 04/24/2003 | WO2002072822A3 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 04/24/2003 | WO2002066507A3 Histidine phosphatase interacting protein of 120 kd |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002051988A3 Thymic epithelial progenitor cells and uses thereof |
| 04/24/2003 | WO2002050120A3 High affinity antibodies |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002046227A3 Glp-1 fusion proteins |
| 04/24/2003 | WO2002040688A3 Maize yellow stripe1 and related genes |
| 04/24/2003 | WO2002035990A9 Supported lattice for cell cultivation |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002012447A3 Isolation and use of solid tumor stem cells |
| 04/24/2003 | WO2002006490A8 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 04/24/2003 | WO2001077389A3 Genes expressed in foam cell differentiation |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | US20030079255 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid |
| 04/24/2003 | US20030079253 Immunoglobulin binding protein arrays in eukaryotic cells |
| 04/24/2003 | US20030079250 Nucleotide sequences coding polypetide for use in the modification of fatty acids in plants |
| 04/24/2003 | US20030079246 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 04/24/2003 | US20030079239 Nucleotide sequences coding polypeptide for use in the treatment of osteoporosis |
| 04/24/2003 | US20030079238 Polynucleotide encoding a human junctional adhesion protein (JAM-2) |
| 04/24/2003 | US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |